MSRB (msrB) is a member of the methionine sulfoxide reductase family, specializing in the stereospecific reduction of Met-R-SO residues in proteins and free methionine sulfoxide. It operates alongside MSRA (which reduces Met-S-SO) and other auxiliary enzymes like BisC and fRMsr to ensure cellular methionine homeostasis .
Property | Value |
---|---|
Molecular Weight | 17.6 kDa |
Amino Acids | 157 (1–137 a.a. with His-tag) |
Metal Binding Site | Two CXXC motifs (zinc/iron) |
Source | Recombinant E. coli |
Purity | >95% (SDS-PAGE validated) |
MSRB exhibits distinct substrate preferences compared to other reductases:
MSRB’s low activity in crude extracts contrasts with its essential role in E. coli survival. Genetic studies reveal that msrA msrB mutants retain viability due to compensatory enzymes like BisC and fRMsr .
BisC: A biotin sulfoxide reductase with dual roles. It reduces free Met-S-SO (Kₘ = 17 μM) but lacks activity on protein-bound residues .
fRMsr: A high-efficiency reductase for free Met-R-SO, identified via proteomic analysis in msrA msrB mutants .
msrA msrB bisC mutants lose the ability to assimilate Met-S-SO, confirming BisC’s role in Met-S-SO metabolism .
MSRB deficiency increases E. coli susceptibility to hypochlorous acid (HOCl), highlighting its role in oxidative stress resistance .
MsrB in E. coli is an enzyme that specifically reduces the R-enantiomer of methionine sulfoxide (Met-(R)-O) within proteins, converting it back to methionine. This enzyme is part of a repair system that protects proteins from oxidative damage by reactive oxygen species (ROS). MsrB works in concert with other methionine sulfoxide reductases to maintain protein integrity during oxidative stress conditions. The enzyme exhibits stereospecificity, meaning it only reduces the R-form of methionine sulfoxide, while other enzymes like MsrA reduce the S-form .
E. coli contains several distinct methionine sulfoxide reductases with different specificities:
MsrA: Reduces free Met-(S)-O and Met-(S)-O within peptides or proteins
MsrB: Primarily reduces Met-(R)-O within peptides or proteins, but has poor activity against free Met-(R)-O
fRMsr: Specifically reduces free Met-(R)-O with 100-1000 fold higher activity than MsrB for this substrate
fSMsr: Reduces free Met-(S)-O
MsrP: A periplasmic reductase that works with membrane-bound MsrQ to reduce MetO in periplasmic proteins
This family of enzymes allows E. coli to repair methionine oxidation in various cellular compartments and contexts, providing comprehensive protection against oxidative damage .
The stereospecificity of methionine sulfoxide reductases is crucial because methionine oxidation produces two stereoisomers: Met-(S)-O and Met-(R)-O. Since these enzymes can only reduce specific forms, E. coli needs both MsrA and MsrB to fully repair oxidized methionine residues in proteins. The stereospecificity also suggests evolutionary pressure to maintain repair mechanisms for both forms of methionine sulfoxide, underlining the biological importance of these repair systems in oxidative stress responses. Without this specificity, organisms would be unable to fully repair oxidative damage to methionine residues, potentially leading to protein dysfunction and cellular damage .
MsrB expression in E. coli is regulated by the small RNA (sRNA) RyhB, which is itself regulated by the iron-responsive transcriptional repressor Fur. Under iron-depleted conditions, Fur repression is relieved, leading to increased RyhB levels. RyhB then down-regulates msrB transcripts by binding to two distinct sequences within the short 5′UTR of msrB mRNA. This interaction, facilitated by the RNA chaperone Hfq and RNase E, prevents efficient ribosome binding and inhibits translation initiation. Mutations in the ryhB, fur, hfq, or RNase E-encoded genes result in iron-insensitive expression of msrB, confirming this regulatory pathway. Interestingly, MsrA expression is not influenced by changes in iron levels, suggesting distinct regulatory mechanisms for different Msr enzymes .
The crystal structure of E. coli fRMsr reveals that it belongs to the GAF domain family, making it the first member of this family to show enzymatic activity. The structural features that enable its specificity for free Met-(R)-O include:
Three cysteine residues (Cys84, Cys94, and Cys118) that are critical for catalysis
Formation of a disulfide bond that encloses a small active site cavity
A restricted active site that can accommodate free Met-(R)-O but excludes larger substrates like peptide-bound MetO
This restricted active site is likely the key determinant of substrate specificity, allowing fRMsr to efficiently reduce free Met-(R)-O while excluding peptide-bound MetO. The structural similarity between E. coli and yeast fRMsr proteins suggests this mechanism is conserved across species .
Contrary to the traditional view that methionine oxidation occurs primarily under aerobic conditions, recent research has shown that MsrPQ is highly expressed even in the absence of oxygen. This is due to chlorate (ClO₃⁻) contamination that can be present in growth media components like Casamino Acids. Under anaerobic conditions, E. coli's nitrate reductases (NarA, NarZ, and Nap) reduce chlorate to chlorite (ClO₂⁻), a toxic oxidizing agent that causes methionine oxidation of periplasmic proteins. In response to this stress, the E. coli HprSR two-component system is activated, leading to overproduction of MsrPQ. This reveals that methionine oxidation can occur during anaerobiosis and suggests that MsrPQ functions as an anti-chlorate/chlorite defense system. This finding challenges the conventional understanding of protein oxidation and repair mechanisms in anaerobic environments .
Two primary methods are used to measure MsrB activity in E. coli extracts:
Nitroprusside Assay: This method detects the formation of methionine from methionine sulfoxide. Methionine reacts with nitroprusside, leading to a change in absorbance at 540 nm. When using this method, it's important to note that ammonium sulfate inhibits Msr activity, necessitating dialysis of samples before analysis.
NADPH Oxidation Assay: This method monitors the decrease in NADPH absorbance at 340 nm as it provides reducing equivalents through the thioredoxin system. The complete assay mixture contains:
NADPH (typically 200-250 μM)
Thioredoxin reductase (TrxR)
Thioredoxin (Trx)
Methionine sulfoxide substrate
The MsrB enzyme
For kinetic characterization, researchers can vary substrate concentrations (0.5–6.5 mM Met-(R)-O) and cofactor concentrations (2–30 μM eTrx) while maintaining a fixed enzyme concentration (e.g., 72 nM fRMsr). Results can be fit to the Michaelis-Menten equation using nonlinear regression analysis .
The purification of native methionine sulfoxide reductases from E. coli typically involves:
Strain Selection: Use of an appropriate strain, such as an MsrA⁻B⁻ knockout strain for purifying fRMsr, to reduce interference from other Msr activities
Extraction and Fractionation:
Cell lysis (typically by sonication)
Ammonium sulfate precipitation (with subsequent dialysis to remove inhibitory ammonium sulfate)
Sequential chromatography:
Ion exchange chromatography
Size exclusion chromatography
Affinity chromatography (if applicable)
Activity Assays: Throughout purification, fractions are tested for MetO reductase activity using the nitroprusside or NADPH oxidation assays
Protein Identification: Final confirmation of the purified protein can be performed by:
SDS-PAGE analysis
Mass spectrometry
N-terminal sequencing
Enzymatic activity with specific substrates
This approach has been successfully used to identify and characterize fRMsr from E. coli extracts. For recombinant protein production, genes can be cloned into expression vectors with appropriate tags for simplified purification .
Several techniques have been employed to study the interaction between RyhB sRNA and msrB mRNA:
Reverse Transcriptase Protection Assay: This method identifies the binding sites of RyhB on msrB mRNA by detecting areas protected from reverse transcriptase by the bound sRNA.
RNase and Lead(II) Protection Assays: These assays detect regions of RNA that are protected from enzymatic or chemical cleavage due to RNA-RNA interactions.
Toeprinting Analysis: This technique determines the effect of RyhB binding on ribosome binding to msrB mRNA, revealing that RyhB prevents efficient ribosome binding and thereby inhibits translation initiation.
In vivo Site-Directed Mutagenesis: By creating mutations in the msrB 5′UTR region and observing their effects on RyhB regulation, researchers determined that both RyhB-pairing sites are required to decrease msrB expression.
Reporter Gene Fusions: Constructing fusions between msrB regulatory regions and reporter genes allows quantitative assessment of RyhB-mediated regulation under various conditions.
These methodologies have revealed that RyhB binds to two distinct sequences within the 5′UTR of msrB mRNA, establishing a novel mechanism of translational regulation where a single sRNA can pair with two different locations within the same mRNA species .
Kinetic parameters for MsrB and related reductases should be determined using:
Steady-state kinetics: Varying substrate and cofactor concentrations while maintaining fixed enzyme concentration to generate initial velocity data.
Data fitting to appropriate models: Typically the Michaelis-Menten equation for simple kinetics, using nonlinear regression analysis.
Parameter extraction:
KM: Substrate concentration at which reaction rate is half-maximum
kcat: Turnover number (catalytic rate constant)
kcat/KM: Catalytic efficiency
For example, E. coli fRMsr has been characterized with the following parameters:
KM for Met-(R)-O: 3.9 ± 0.4 mM
kcat: 6.9 ± 0.4 s⁻¹
kcat/KM: 1769 ± 181 M⁻¹s⁻¹
KM for E. coli Trx: 9.8 ± 0.9 μM
When comparing different reductases, it's important to:
Use consistent assay conditions
Compare catalytic efficiency (kcat/KM) rather than individual parameters
Consider substrate specificity profiles alongside kinetic parameters
Note the reducing system used (typically NADPH-TrxR-Trx)
For instance, E. coli fRMsr is 100- to 1,000-fold more active than non-selenocysteine-containing MsrB enzymes for free Met-(R)-O, highlighting its specialized role .
Resolving contradictions in methionine sulfoxide reductase activity data requires systematic investigation of several factors:
Assay Methodology Differences:
Different detection methods (nitroprusside assay vs. NADPH oxidation)
Variations in assay components or concentrations
Presence of inhibitory compounds (e.g., ammonium sulfate)
Substrate Considerations:
Purity and stereochemical composition of MetO preparations
Use of free MetO versus peptide-bound MetO
Substrate concentration ranges
Enzyme Source Variability:
Crude extracts versus purified enzymes
Native versus recombinant proteins
Presence of tags or fusion partners
Enzyme storage conditions and stability
Strain Differences:
Genetic background of E. coli strains
Presence of other Msr enzymes
Growth conditions affecting enzyme expression
For example, the apparent contradiction between poor MsrB activity against free Met-(R)-O in vitro and the ability of E. coli methionine auxotrophs to grow on Met-(R)-O was resolved by the discovery of fRMsr, which specifically reduces free Met-(R)-O with much higher efficiency .
Investigating the global impacts of MsrB function on E. coli physiology under oxidative stress can be approached through:
Multi-omics Approaches:
Transcriptomics: RNA-seq to identify genes differentially expressed in MsrB mutants
Proteomics: Mass spectrometry to identify proteins affected by methionine oxidation
Metabolomics: Analysis of metabolic changes in response to oxidative stress in wild-type versus MsrB mutants
Physiological Characterization:
Growth curve analysis under various oxidative stressors
Survival assays following acute oxidative stress
Measurement of intracellular ROS levels
Analysis of protein carbonylation as a marker of oxidative damage
Genetic Approaches:
Construction of single and multiple Msr mutants to assess redundancy
Suppressor screens to identify genes that compensate for MsrB deficiency
Synthetic genetic arrays to identify genetic interactions
Biochemical Characterization:
Identification of MsrB protein substrates using trapping mutants
Assessment of structural and functional changes in identified substrates
Determination of the redox state of the cellular thioredoxin pool
Recent findings on anaerobic methionine oxidation demonstrate the importance of examining MsrB function under diverse conditions, including those traditionally not associated with oxidative stress. The connection between iron homeostasis and MsrB regulation via RyhB further suggests the importance of integrating MsrB studies with broader cellular stress response networks .
Several emerging areas in MsrB and methionine sulfoxide reductase research include:
Methionine Oxidation as a Signaling Mechanism: The discovery that Met-(R)-O may represent a signaling molecule in response to oxidative stress and nutrients via the TOR pathway suggests a regulatory role beyond simple damage repair.
Non-Oxidative Functions of Msr Enzymes: Investigation of potential roles of these enzymes beyond oxidative damage repair, possibly in protein folding, cellular homeostasis, or metabolic regulation.
MsrPQ System in Antimicrobial Resistance: The finding that MsrPQ serves as an anti-chlorate/chlorite defense system opens new avenues for understanding bacterial resistance to antimicrobial compounds and disinfectants.
Anaerobic Methionine Oxidation: The discovery of methionine oxidation under anaerobic conditions challenges traditional views and expands the importance of Msr enzymes to diverse growth conditions.
RNA-Based Regulation of Stress Responses: The complex regulation of MsrB by RyhB provides insights into how small RNAs coordinate cellular responses to environmental stresses, connecting iron homeostasis with protein repair mechanisms.
These emerging areas highlight the evolving understanding of methionine sulfoxide reductases from simple repair enzymes to sophisticated components of complex cellular regulatory networks involved in stress responses, metabolism, and potentially bacterial pathogenesis .
Understanding MsrB in E. coli has several potential applications in biotechnology and medicine:
Protein Engineering:
Development of oxidation-resistant proteins for industrial applications
Engineering of Msr enzymes with enhanced catalytic properties
Creation of biosensors for detecting oxidative stress
Therapeutic Applications:
Design of new antimicrobial strategies targeting bacterial Msr systems
Development of drugs that modulate methionine oxidation for treating oxidative stress-related conditions
Potential use of Msr enzymes as therapeutic agents to repair oxidized proteins
Biotechnological Applications:
Improvement of recombinant protein production by preventing oxidative damage
Enhancement of bacterial strain resistance to industrial oxidative stressors
Development of bacteria with improved bioremediation capabilities for environments containing oxidative pollutants
Model Systems for Human Disease:
Using E. coli Msr systems to understand human methionine sulfoxide reductases, which have been implicated in aging, neurodegenerative diseases, and cancer
Screening of compounds that modulate Msr activity for potential therapeutic applications
The unique properties of E. coli methionine sulfoxide reductases, particularly their strict stereospecificity and the novel regulatory mechanisms controlling their expression, provide valuable insights that can be translated into various applications spanning from fundamental research to applied biotechnology and medicine .
Methionine Sulfoxide Reductase B (MsrB) is an enzyme that plays a crucial role in the reduction of methionine-R-sulfoxide back to methionine. This process is essential for protecting cells from oxidative damage and maintaining protein function. The recombinant form of this enzyme, expressed in Escherichia coli (E. coli), is widely used in research to study its structure, function, and potential therapeutic applications.
MsrB belongs to the methionine sulfoxide reductase family and is characterized by its ability to reduce methionine-R-sulfoxide to methionine. This enzyme contains a metal-binding site composed of two CXXC motifs, which can bind zinc or iron. The bound metal ions help stabilize the enzyme’s conformation, ensuring its proper function .
The recombinant MsrB protein from E. coli is typically fused to a His-tag at the N-terminus, which facilitates its purification using conventional chromatography techniques . The protein has a molecular weight of approximately 17.6 kDa and consists of 137 amino acids .
The recombinant MsrB protein is expressed in E. coli and purified using proprietary chromatographic techniques. The expression system in E. coli allows for high-yield production of the protein, making it suitable for various research applications . The purified protein is often used in studies involving protein structure, enzyme kinetics, and oxidative stress response.
Recombinant MsrB protein is used in a wide range of research applications, including: